Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity. [electronic resource]
Producer: 20100302Description: 1585-6 p. digitalISSN:- 1556-1380
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Mutation -- genetics
- Neoplasm Recurrence, Local -- drug therapy
- Prognosis
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Skin Diseases -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.